Dr. Stephen A Smith EurChem CSci CChem FRSC
|
|
Enhancing and Facilitating Drug Discovery |
|
Dr. Stephen A Smith EurChem CSci CChem FRSC |
| Home | Experience | Publications | Professional Bodies | Meetings | Contact |
|
The following is a selection of forthcoming meetings of interest to those in Drug Discovery and Development
Details Organised by Society of Chemical Industry This event will showcase drug discovery programmes derived from academia. Case studies will be presented to highlight the latest scientific advances and to provide illustrations of how different types of funded collaborations between academia and industry have led, and are leading to, successful drug candidates. Representatives from both academia and the pharmaceutical industry will be in attendance to share their insights, together with ample networking opportunities./br>
Details Organised by Society of Medicines Research An international line-up of speakers present on the search for drugs for the treatment of Alzheimer’s disease
Details Organised by Royal Society of Chemistry This symposium covers progress in the interdisciplinary field of Chemical Biology in enhancing our understanding of the molecular mechanisms of human biology in health and disease. Topics will include discovery and use of chemical probes, chemical modification of biological molecules, in-cell protein labelling, carbohydrate therapeutics and biomarkers, and the study of protein-protein interactions.
Details Organised by Society of Chemical Industry The aim of the day is to provide participants with a fundamental understanding of Epigenetics and how it relates to Drug Discovery, from an introduction to the underpinning biology and the discovery of novel therapeutics targets to the development of chemical probes and small molecule inhibitors. The day will comprise of a series of lectures from some of the leading names in Epigenetic research from both UK academia and industry.
Details Organised by Royal Society of Chemistry and Israeli Chemical Society An international line-up of speakers present on topics in Medicinal Chemistry.
Details Organised by Royal Society of Chemistry. The next incarnation of this highly popular meeting on Medicinal Chemistry.
Details Organised by Society of Chemical Industry and Royal Society of Chemistry in Partnership with Accelrys This symposium will detail recent progress in the area of Protein Kinases and address the challenges and issues associated with converting kinase inhibitors into clinical compounds in oncology but also in non-oncology settings. There will be talks on how some of the latest technologies are being applied to PK inhibitor programmes to help identify the next generation of drugs that act on this family of enzymes as well as the first disclosure of some recent clinical candidates.
Details Organised by Royal Society of Chemistry Organic chemistry is a core area of chemistry. Fundamental research in synthesis is leading to innovation through process improvement and invention of new types of transformations. Novel procedures can create the new substances which society needs to develop.
Details Organised jointly organised by the German Chemical Society and the German Pharmaceutical Society on behalf of the European Federation for Medicinal Chemistry (EFMC). The meeting will continue its tradition and cover advances in drug discovery in all major therapeutic areas as well as the most recent advances in lead identification and optimization strategies, drug design and profiling technologies. Particular emphasis will be put on first time disclosures. ISMC 2012 will also illustrate the impact of the -omics and biomarker areas on the interfaces between chemistry, informatics, biology and experimental medicine.
Details Organised by Society of Chemical Industry and Royal Society of Chemistry Building on the success of the previous three meetings, this next meeting will cover topics such as: New technologies in GPCR research, GPCR activation, Lead generation approaches, GPCR peptide receptors, Allosteric modulation of GPCRs, Structural biology and drug design. |
|